High-Shear Microfluidic Thrombosis Assay
Completed
Conditions studied: Coagulation Defects, Other and Unspecified
In brief
The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
Key facts
- Study ID
- NCT02422810
- Run by
- Emory University
- People needed
- 16
- Starts
- 2015-05-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2018-06-07
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- a known bleeding or thrombotic disorder
- Exclusion Criteria for "new to aspirin" group:
- a known bleeding or thrombotic disorder
- have taken aspirin, other NSAIDs, clopidogrel, or an anticoagulant in the previous 10 days
Where it is running
- Emory Clinic — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.